Kim Wadt Hansen

Kim Wadt Hansen

Auto-generated profile, based on publicly available information

Kim Wadt Hansen

Department of Cardiology, Copenhagen University Hospital Gentofte, Hellerup, Denmark

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2017 in Epidemiology and Health
Verified
Journal Article
Open access
PDF file
TLTheis Lange
Theis Lange
KHKim Wadt Hansen
Kim Wadt Hansen
RSRikke Sørensen
Rikke Sørensen
SGSøren Galatius
Søren Galatius
•Yi (a, m) is the outcome achieved for person i if, possibly contrary to fact, exposure had been set to a and mediator to m.

1 August 2023 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Closed access
SHSigne Højstrup
Signe Højstrup
KHKim W. Hansen
Kim W. Hansen
UTUlrik Talleruphuus
Ulrik Talleruphuus
LMLisbeth Marner
Lisbeth Marner
LBLouise Bjerking
Louise Bjerking
EPEva Prescott
Eva Prescott
BACKGROUND: Rubidium-82 positron emission tomography ( 82 Rb PET) myocardial perfusion imaging is used in clinical practice to quantify regional perfusion defects. Additionally, 82 Rb PET provides a measure of absolute myocardial flow reserve (MFR), describing the vasculature state of health. We assessed whether 82 Rb PET-derived MFR is associated with all-cause mortality independently of the extent of perfusion defects. METHODS: We conducted a multicenter clinical registry-based study of patients undergoing 82 Rb PET myocardial perfusion imaging on suspicion of chronic coronary syndromes. Patients were followed up in national registries for the primary outcome of all-cause mortality. Global MFR ≤2 was considered reduced. RESULTS: Among 7169 patients studied, 38.1% were women, the median age was 69 (IQR, 61–76) years, and 39.0% had MFR ≤2. A total of 667 (9.3%) patients died during a median follow-up of 3.1 (IQR, 2.6–4.0) years, more in patients with MFR ≤2 versus MFR >2 (15.7% versus 5.2%; P <0.001). MFR ≤2 was associated with all-cause mortality across subgroups defined by the extent of perfusion defects (all P <0.05). In a Cox survival regression model adjusting for sex, age, comorbidities, kidney function, left ventricular ejection fraction, and perfusion defects, MFR ≤2 was a robust predictor of mortality with a hazard ratio of 1.62 (95% CI, 1.31–2.02; P <0.001). Among patients with no reversible perfusion defects (n=3101), MFR ≤2 remained strongly associated with mortality (hazard ratio, 1.86 [95% CI, 1.26–2.73]; P <0.01). The prognostic value of impaired MFR was similar for cardiac and noncardiac death. CONCLUSIONS: MFR ≤2 predicts all-cause mortality independently of the extent of perfusion defects. Our results support the inclusion of MFR when assessing the prognosis of patients suspected of chronic coronary syndromes.

1 September 2013 in International Journal of Cardiology
Verified
Journal Article
Closed access
KHKim Wadt Hansen
Kim Wadt Hansen
AHAnders Hvelplund
Anders Hvelplund
SASteen Zabell Abildstrøm
Steen Zabell Abildstrøm
EPEva Prescott
Eva Prescott
MMMette Madsen
Mette Madsen
SGSøren Galatius
Søren Galatius

10 June 2015 in BMJ Open
Verified
Journal Article
Open access
PDF file
KHKim Wadt Hansen
Kim Wadt Hansen
RSR Soerensen
R Soerensen
MMM Madsen
M Madsen
JMJ K Madsen
J K Madsen
JJJ S Jensen
J S Jensen
SGS Galatius
S Galatius
Objectives To investigate for trends in sex-related differences in the invasive diagnostic–therapeutic cascade in a population of patients with acute coronary syndromes (ACS). Design A nationwide cohort study. Setting Administrative and clinical registries covering all hospitalisations, invasive cardiac procedures and deaths in the Danish population of 5.6 million inhabitants. Participants We included 52 565 patients aged 30–90 years who were hospitalised with a first ACS from January 2005 to November 2011. Follow-up was 60 days from the day of index admission. Main outcome measures Diagnostic coronary angiography, percutaneous coronary intervention or coronary artery bypass within 60 days of index admission. Results Women constituted 36%, were older, had more comorbidity and were less likely to be admitted to a hospital with cardiac catheterisation facilities than men. Mortality rates were similar for both sexes. Diagnostic coronary angiography was performed less frequently on women compared with men, both within 1 day (31% vs 42%; p<0.001) and within 60 days (67% vs 80%; p<0.001), yielding adjusted female–male HRs of 0.83 (0.79–0.87) and 0.86 (0.84–0.89), respectively.Among the 39 677 patients undergoing coronary angiography, non-obstructive coronary artery disease was more frequent among women than men (22% vs 9%; p<0.001). Women were less likely to undergo percutaneous coronary intervention (58% vs 72%; p<0.001) and coronary artery bypass (6% vs 11%, p0.05). Conclusions In this nationwide study, men were more likely to undergo an invasive approach than women when hospitalised with a first ACS—a difference persisting from 2005 to 2011. Future studies should focus on the potential mechanisms behind this differential treatment.

20 June 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
SHSigne Højstrup
Signe Højstrup
KHKim W. Hansen
Kim W. Hansen
UTUlrik Talleruphuus
Ulrik Talleruphuus
LMLisbeth Marner
Lisbeth Marner
SGSøren Galatius
Søren Galatius
EPEva I. B. Prescott
Eva I. B. Prescott
Background: Coronary microvascular disease (CMD) may be part of a systemic small vessel disease that also manifests as neurological impairment and kidney disease. However, clinical evidence supporting a potential link is scarce. We assessed whether CMD is associated with an increased risk of small vessel disease in the kidney and brain. Methods and Results: A retrospective multicenter (n=3) study of patients clinically referred to 82‐rubidium positron emission tomography myocardial perfusion imaging was conducted between January 2018 and August 2020. Exclusion criterion was reversible perfusion defects >5%. CMD was defined as myocardial flow reserve (MFR) ≤2. The primary outcome, microvascular event, was defined by hospital contact for chronic kidney disease, stroke, or dementia. Among 5122 patients, 51.7% were men, median age 69.0 [interquartile range, 60.0–75.0] years, 11.0% had left ventricular ejection fraction ≤40%, and 32.4% had MFR ≤2. MFR was associated with baseline estimated glomerular filtration rate after multivariable adjustment ( β =0.04 [95% CI, 0.03–0.05]; P 2 (11.6% versus 5.5%, P <0.001). MFR ≤2 was associated to outcome with a hazard ratio (HR) of 2.30 (95% CI, 1.88–2.81, P <0.001) and an adjusted HR of 1.62 (95% CI, 1.32–2.00, P <0.001). Results were consistent across subgroups defined by presence of irreversible perfusion defects, estimated glomerular filtration rate, diabetes, left ventricular ejection fraction, and previous revascularization. Conclusions: This is the first large‐scale cohort study to link CMD to microvascular events in the kidney and brain. Data support the hypothesis that CMD is part of a systemic vascular disorder.

10 February 2021 in European Journal of Preventive Cardiology
Verified
Journal Article
Open access
PDF file
KHKim Wadt Hansen
Kim Wadt Hansen
NPNina Peytz
Nina Peytz
ABAnneke Blokstra
Anneke Blokstra
SBStig E Bojesen
Stig E Bojesen
CCCarlos Celis-Morales
Carlos Celis-Morales
EPEva Prescott
Eva Prescott
To assess the association between past level of physical activity (PA) and risk for death during the acute phase of myocardial infarction (MI) in a pooled analysis of cohort studies. European cohorts including participants with a baseline assessment of PA, conventional cardiovascular (CV) risk factors, and available follow-up on MI and death were eligible. Patients with an incident MI were included. Leisure-time PA was grouped as sedentary (32 MET-hours) based on calculated net weekly energy expenditure. The main outcome measures were instant and 28-day case fatality of MI. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using multivariate random-effects models. Adjustments for age, sex, CV risk factors, alcohol consumption, and socioeconomic status were made. From 10 cohorts including a total of 1 495 254 participants, 28 140 patients with an incident MI comprised the study population. A total of 4976 (17.7%) died within 28 days—of these 3101 (62.3%) were classified as instant fatal MI. Compared with sedentary individuals, those with a higher level of PA had lower adjusted odds of instant fatal MI: low PA [OR, 0.79 (95% CI, 0.60–1.04)], moderate PA [0.67 (0.51–0.89)], and high PA [0.55 (0.40–0.76)]. Similar results were found for 28-day fatal MI: low PA [0.85 (0.71–1.03)], moderate PA [0.64 (0.51–0.80)], and high PA [0.72 (0.51–1.00)]. A low-to-moderate degree of heterogeneity was detected in the analysis of instant fatal MI (I2 = 47.3%), but not in that of 28-day fatal MI (I2 = 0.0%). A moderate-to-high level of PA was associated with a lower risk of instant and 28-day death in relation to a MI.